Evaluation of the performance of SARS-CoV-2 serological tools and their positioning in COVID-19 diagnostic strategies.
A. Velay, F. Gallais, I. Benotmane, M.-J. Wendling, F. Danion, O. Collange, J. De Seze, C. Schmidt-Mutter, F. Schneider, P. Bilbault, F. Meziani, S. Fafi-Kremer
This study evaluates the performance of SARS-CoV-2 serological tools across different panels and timepoints, finding varying sensitivities and specificities with poor agreement between assays.
bioRxiv · Jun 16, 2020Microbiology